Article
FTC Uses Its Consumer Protection Powers To Regulate Sellers Of GLP-1s
On July 14, 2025, the FTC announced its enforcement action against telemedicine company NextMed over charges it used misleading prices, fake reviews and deceptive weight-loss claims to sell GLP-1 weight-loss drugs.
Crowell & Moring LLP